24 research outputs found
Cognitive function prior to systemic therapy and subsequent wellâbeing in older breast cancer survivors: Longitudinal findings from the Thinking and Living with Cancer Study
ObjectiveTo investigate the relationships between selfâreported and objectively measured cognitive function prior to systemic therapy and subsequent wellâbeing outcomes over 24âmonths in older breast cancer survivors.MethodsData were from 397 women aged 60 to 98 diagnosed with nonâmetastatic breast cancer in the Thinking and Living with Cancer Study recruited from 2010â2016. Cognitive function was measured at baseline (following surgery, prior to systemic therapy) using neuropsychological assessments of attention, processing speed, and executive function (APE), learning and memory (LM), and the selfâreported FACTâCog scale. Wellâbeing was measured using the FACTâG functional, physical, social, and emotional wellâbeing domain scales at baseline and 12 and 24âmonths later, scaled from 0 (low) to 100 (high). Linear mixedâeffects models assessed the relationships between each of baseline APE, LM, and FACTâCog quartiles with wellâbeing scores over 24âmonths, adjusted for confounding variables.ResultsAt baseline, older survivors in the lowest APE, LM, and FACTâCog score quartiles experienced poorer global wellâbeing than those in the highest quartiles. At 24âmonths, older survivors tended to improve in wellâbeing, and there were no differences according to baseline APE or LM scores. At 24âmonths, mean global wellâbeing was 80.3 (95% CI: 76.2â84.3) among those in the lowest vs 86.6 (95% CI: 83.1â90.1) in the highest FACTâcog quartile, a clinically meaningful difference of 6.3 points (95% CI: 1.5â11.1).ConclusionsAmong older breast cancer survivors, selfâreported, but not objective cognitive impairments, were associated with lower global wellâbeing over the first 2âyears of survivorship.Peer Reviewedhttps://deepblue.lib.umich.edu/bitstream/2027.42/155908/1/pon5376.pdfhttps://deepblue.lib.umich.edu/bitstream/2027.42/155908/2/pon5376_am.pd
Pre-treatment psychoneurological symptoms and their association with longitudinal cognitive function and quality of life in older breast cancer survivors
Context
Symptoms affect quality of life (QOL), functional status, and cognitive function in cancer survivors, but older survivors are understudied.
Objectives
To identify prototypical pre-systemic therapy psychoneurological symptom clusters among older breast cancer survivors, and determine whether these symptom clusters predicted cognition and QOL over time.
Methods
Women with newly diagnosed non-metastatic breast cancer (n=319) and matched non-cancer controls (n=347) aged 60+ completed questionnaires and neuropsychological tests before systemic therapy and 12- and 24-months later. Latent class analysis identified clusters of survivors based upon their pre-therapy depression, anxiety, fatigue, sleep disturbance, and pain. Linear mixed-effects models examined changes in objective cognition, perceived cognition, and functional status (instrumental activities of daily living (IADL) disability, functional well-being, and breast cancer-specific QOL) by group, controlling for covariates.
Results
Nearly one-fifth of older survivors were classified as having a high pre-therapy symptoms (n=51; 16%); the remainder had a low symptoms (n=268; 84%); both groups improved over time on all outcomes. However, compared to the low symptom group and controls, survivors with high symptoms had lower baseline objective cognition and lower perceived cognition at baseline and 24-months, lower functional well-being at baseline and 12-months, greater IADL disability at baseline, and lower breast cancer-specific QOL at all time points (all p<0.05).
Conclusion
Nearly one-fifth of older breast cancer survivors had high psychoneurological symptoms at diagnosis, which, predict clinically meaningful decrements in perceived cognition and function in the first 24 months post-diagnosis. Pre-treatment psychoneurological symptom clusters could identify survivors for monitoring or intervention
Symptom burden among older breast cancer survivors: The Thinking and Living With Cancer (TLC) study
Background:
Little is known about longitudinal symptom burden and its consequences for well-being, and if lifestyle moderates burden in older survivors.
Methods:
We report on 36-month data from survivors 60+ with newly diagnosed non-metastatic breast cancer and non-cancer controls recruited August 2010-June 2016. Symptom burden was a sum of self-reported symptoms/diseases: pain (yes/no), fatigue (FACT-fatigue), cognitive (FACT-cog), sleep problems (yes/no), depression (CES-D), anxiety (STAI), and cardiac problems and neuropathy (yes/no). Well-being was measured using the FACT-G, scaled from 0â100. Lifestyle included smoking, alcohol use, BMI, physical activity, and leisure activities. Mixed models assessed relationships between treatment group (chemotherapy +/â hormonal, hormonal only, control) and symptom burden, lifestyle, and covariates. Separate models tested the effects of fluctuations in symptom burden and lifestyle on function.
Results:
All groups reported high baseline symptoms, and levels remained high over time; survivor-control differences were most notable for cognitive and sleep problems, anxiety, and neuropathy. The adjusted burden score was highest among chemotherapy-exposed survivors, followed by hormonal therapy vs. controls (p<.001). Burden score was related to physical, emotional, and functional well-being (e.g., survivors with lower vs. higher burden scores had 12.4-point higher physical well-being score). The composite lifestyle score was not related to symptom burden or well-being, but physical activity was significantly associated with each outcome (<.005).
Conclusions:
Cancer and its treatments are associated with a higher level of actionable symptoms and greater loss of well-being over time in older breast cancer survivors than comparable non-cancer populations, suggesting the need for surveillance and opportunities for intervention
Recommended from our members
GWAS Identifies Novel Susceptibility Loci on 6p21.32 and 21q21.3 for Hepatocellular Carcinoma in Chronic Hepatitis B Virus Carriers
Genome-wide association studies (GWAS) have recently identified KIF1B as susceptibility locus for hepatitis B virus (HBV)ârelated hepatocellular carcinoma (HCC). To further identify novel susceptibility loci associated with HBVârelated HCC and replicate the previously reported association, we performed a large three-stage GWAS in the Han Chinese population. 523,663 autosomal SNPs in 1,538 HBVâpositive HCC patients and 1,465 chronic HBV carriers were genotyped for the discovery stage. Top candidate SNPs were genotyped in the initial validation samples of 2,112 HBVâpositive HCC cases and 2,208 HBV carriers and then in the second validation samples of 1,021 cases and 1,491 HBV carriers. We discovered two novel associations at rs9272105 (HLA-DQA1/DRB1) on 6p21.32 (OR = 1.30, P = 1.13Ă) and rs455804 (GRIK1) on 21q21.3 (OR = 0.84, P = 1.86Ă), which were further replicated in the fourth independent sample of 1,298 cases and 1,026 controls (rs9272105: OR = 1.25, P = 1.71Ă; rs455804: OR = 0.84, P = 6.92Ă). We also revealed the associations of HLA-DRB1*0405 and 0901*0602, which could partially account for the association at rs9272105. The association at rs455804 implicates GRIK1 as a novel susceptibility gene for HBVârelated HCC, suggesting the involvement of glutamate signaling in the development of HBVârelated HCC
Protective Effects of APOE Δ2 Genotype on Cognition in Older Breast Cancer Survivors: The Thinking and Living With Cancer Study
Background: Cancer-related cognitive decline (CRCD) has been linked to apolipoprotein E (APOE) gene Δ4 polymorphisms. APOE Δ4 polymorphisms are also the strongest genetic risk for late-onset Alzheimer disease (AD), whereas Δ2 polymorphisms protect against AD. However, the effects of Δ2 polymorphisms on CRCD have not been evaluated.
Methods: We evaluated nonmetastatic breast cancer survivors (n = 427) and matched noncancer controls (n = 407) ages 60-98 years assessed presystemic therapy from August 2010 to December 2017 with annual follow-up to 24 months. Neuropsychological assessment measured attention, processing speed, executive function, and learning and memory. Linear mixed-effects models tested the effects of having an Δ2 allele (vs none) on longitudinal cognitive domain z scores by treatment group (chemotherapy with or without hormonal therapy, hormonal therapy, and control) controlling for covariates; participants with Δ2/Δ4 genotype were excluded. Sensitivity analyses examined effects of other covariates and any Δ4 positivity.
Results: There was an interaction with genotype for attention, processing speed, and executive functioning domain scores (Beta = 0.32, 95% confidence interval = 0.00 to 0.65); the chemotherapy group with an Δ2 allele had higher scores at baseline and maintained higher scores over time compared with those without an Δ2 allele, and this protective effect was not seen for other groups. There was no effect of Δ2 on learning and memory domain scores.
Conclusions: APOE Δ2 polymorphisms may protect against CRCD in older breast cancer survivors receiving chemotherapy. With replication, this information could be useful for survivorship care and informing future studies of possible links to AD and defining mechanisms of protection
Loneliness and mental health during the COVIDâ19 pandemic in older breast cancer survivors and noncancer controls
This article is made available for unrestricted research re-use and secondary analysis in any form or be any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.Background: The coronavirus disease 2019 (COVID-19) pandemic has had wide-ranging health effects and increased isolation. Older with cancer patients might be especially vulnerable to loneliness and poor mental health during the pandemic.
Methods: The authors included active participants enrolled in the longitudinal Thinking and Living With Cancer study of nonmetastatic breast cancer survivors aged 60 to 89 years (n = 262) and matched controls (n = 165) from 5 US regions. Participants completed questionnaires at parent study enrollment and then annually, including a web-based or telephone COVID-19 survey, between May 27 and September 11, 2020. Mixed-effects models were used to examine changes in loneliness (a single item on the Center for Epidemiologic Studies-Depression [CES-D] scale) from before to during the pandemic in survivors versus controls and to test survivor-control differences in the associations between changes in loneliness and changes in mental health, including depression (CES-D, excluding the loneliness item), anxiety (the State-Trait Anxiety Inventory), and perceived stress (the Perceived Stress Scale). Models were adjusted for age, race, county COVID-19 death rates, and time between assessments.
Results: Loneliness increased from before to during the pandemic (0.211; P = .001), with no survivor-control differences. Increased loneliness was associated with worsening depression (3.958; P < .001) and anxiety (3.242; P < .001) symptoms and higher stress (1.172; P < .001) during the pandemic, also with no survivor-control differences.
Conclusions: Cancer survivors reported changes in loneliness and mental health similar to those reported by women without cancer. However, both groups reported increased loneliness from before to during the pandemic that was related to worsening mental health, suggesting that screening for loneliness during medical care interactions will be important for identifying all older women at risk for adverse mental health effects of the pandemic
Data Stream Approach for Exploration of Droughts and Floods Driving Forces in the Dongting Lake Wetland
Wetlands are important environmental resources that are vulnerable to droughts and floods. Studying drought-flood events and their driving factors is essential for wetland resource planning and management. However, climate change and human activities present dynamic challenges that traditional approaches are unable to simulate dynamically in a rapidly changing environment. This makes quantitative analysis difficult. Our research focused on the innovative use of the data stream model, namely online bagging of Hoeffding adaptive trees, to quantify drought and flood drivers in response to climate change and human activity. The proposed approach was applied to a river-lake system, the Dongting Lake wetland. The frequency and duration characteristics of drought-flood events were analyzed. In addition, the cyclical changes of droughts and floods were analyzed by wavelet analysis. Then, drought-flood indicators as well as climatic and hydrological factors were entered into a dynamic data stream model for quantitative calculations. The results showed that the water conservancy projects largely reduced flood events while aggravating droughts. The frequency of floods decreased by 4.91% and the frequency of droughts increased by 6.81% following the construction of the Gezhouba Hydro-project and the Three Gorges Dam. Precipitation and Sankou streamflow were two dominant factors in the Dongting Lake drought and flood events, both of which had a feature importance value of approximately 0.3. This research showed how the data stream model can be used in a changing environment and the applicability of the conclusions reached through real-world instances. Moreover, these quantitative outputs can help in the sustainable utilization of Dongting Lake wetland resources
Data Stream Approach for Exploration of Droughts and Floods Driving Forces in the Dongting Lake Wetland
Wetlands are important environmental resources that are vulnerable to droughts and floods. Studying drought-flood events and their driving factors is essential for wetland resource planning and management. However, climate change and human activities present dynamic challenges that traditional approaches are unable to simulate dynamically in a rapidly changing environment. This makes quantitative analysis difficult. Our research focused on the innovative use of the data stream model, namely online bagging of Hoeffding adaptive trees, to quantify drought and flood drivers in response to climate change and human activity. The proposed approach was applied to a river-lake system, the Dongting Lake wetland. The frequency and duration characteristics of drought-flood events were analyzed. In addition, the cyclical changes of droughts and floods were analyzed by wavelet analysis. Then, drought-flood indicators as well as climatic and hydrological factors were entered into a dynamic data stream model for quantitative calculations. The results showed that the water conservancy projects largely reduced flood events while aggravating droughts. The frequency of floods decreased by 4.91% and the frequency of droughts increased by 6.81% following the construction of the Gezhouba Hydro-project and the Three Gorges Dam. Precipitation and Sankou streamflow were two dominant factors in the Dongting Lake drought and flood events, both of which had a feature importance value of approximately 0.3. This research showed how the data stream model can be used in a changing environment and the applicability of the conclusions reached through real-world instances. Moreover, these quantitative outputs can help in the sustainable utilization of Dongting Lake wetland resources
Patientâreported outcomes following autologous stem cell transplant for patients with multiple myeloma
Abstract We evaluated changes in patientâreported outcomes and cognitive function from preâ to 3â6 months postâtreatment among 42 newly diagnosed patients with multiple myeloma undergoing transplant with complete data using PROMISâ29. There were statistically significant improvements in physical (p < .001) and mental health (p < .001) but not cognition from preâtreatment to 3â6 month followâup. Similar results were seen within age or comorbidity strata. Patients with myeloma undergoing transplant experienced generally improved shortâterm health outcomes with no significant declines in cognition
Efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy in esophageal cancer:A systematic review and meta-analysis
Background: Significant progress has been made in the investigation of neoadjuvant immune-chemoradiotherapy (NICRT) and neoadjuvant immune-chemotherapy (NICT) on the outcomes of esophageal cancer patients. To summarize the current developments, a systematic review and meta-analysis were conducted to evaluate the efficacy and safety of neoadjuvant immunotherapy combined with chemoradiotherapy or chemotherapy. Methods: A search strategy of prospective studies on esophageal cancer receiving neoadjuvant immunotherapy was predefined to scan PubMed, Embase, Cochrane, and additional major conferences for prospective studies. Efficacy was assessed by pathological complete response (pCR), major pathological response (MPR), and R0 resection rates. Safety was evaluated based on the incidence of grade â„ 3 treatment-related adverse events (TRAEs), neoadjuvant therapy completion rate, surgical resection rate, and surgical delay rate. Differences between the NICRT and NICT groups were also analyzed. Results: A total of 38 studies qualified for the analysis. The pooled pCR, MPR, and R0 resection rates were 30, 58, and 99%, respectively. The pCR and MPR in the NICRT vs. NICT group were 38% vs. 28% (p=0.078) and 67% vs. 57% (p=0.181), respectively. The pooled incidence of grade â„ 3 TRAEs was 24% (NICRT,58%, I2 = 61% vs. NICT,18%, I2 = 79%;